BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.54% | 15.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.54% | 15.86% | |||
| Cost of Revenue | -6.84% | 25.69% | |||
| Gross Profit | 4.99% | 12.25% | |||
| SG&A Expenses | -5.96% | 23.07% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.54% | 27.88% | |||
| Operating Income | 7.79% | -9.64% | |||
| Income Before Tax | -1.35% | 114.69% | |||
| Income Tax Expenses | -2.64% | 109.81% | |||
| Earnings from Continuing Operations | -0.99% | 116.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.99% | 116.08% | |||
| EBIT | 7.79% | -9.64% | |||
| EBITDA | 6.22% | -8.42% | |||
| EPS Basic | -1.07% | 115.80% | |||
| Normalized Basic EPS | -9.37% | 9.60% | |||
| EPS Diluted | -1.20% | 116.76% | |||
| Normalized Diluted EPS | -9.37% | 9.60% | |||
| Average Basic Shares Outstanding | 0.00% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||